Ontology highlight
ABSTRACT: Background
Type 2 diabetes (T2D) is a heterogeneous disease for which (1) disease-causing pathways are incompletely understood and (2) subclassification may improve patient management. Unlike other biomarkers, germline genetic markers do not change with disease progression or treatment. In this paper, we test whether a germline genetic approach informed by physiology can be used to deconstruct T2D heterogeneity. First, we aimed to categorize genetic loci into groups representing likely disease mechanistic pathways. Second, we asked whether the novel clusters of genetic loci we identified have any broad clinical consequence, as assessed in four separate subsets of individuals with T2D.Methods and findings
In an effort to identify mechanistic pathways driven by established T2
SUBMITTER: Udler MS
PROVIDER: S-EPMC6150463 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature